• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Limitations of the SCORE-guided European guidelines on cardiovascular disease prevention.

作者信息

Mortensen Martin Bødtker, Falk Erling

机构信息

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus, Denmark.

出版信息

Eur Heart J. 2017 Aug 1;38(29):2259-2263. doi: 10.1093/eurheartj/ehw568.

DOI:10.1093/eurheartj/ehw568
PMID:27941016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5946870/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec59/5946870/3e6ea1009695/ehw568f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec59/5946870/2e7d7b7c2b5a/ehw568f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec59/5946870/d9154037b636/ehw568f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec59/5946870/3e6ea1009695/ehw568f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec59/5946870/2e7d7b7c2b5a/ehw568f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec59/5946870/d9154037b636/ehw568f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec59/5946870/3e6ea1009695/ehw568f3.jpg

相似文献

1
Limitations of the SCORE-guided European guidelines on cardiovascular disease prevention.基于SCORE风险评估系统的欧洲心血管疾病预防指南的局限性。
Eur Heart J. 2017 Aug 1;38(29):2259-2263. doi: 10.1093/eurheartj/ehw568.
2
[Polish forum for prevention guidelines on cardiovascular risk assessment].[波兰心血管风险评估预防指南论坛]
Kardiol Pol. 2007 Jan;65(1):100-4.
3
Screening for high-risk cardiovascular disease: a challenge for the guidelines: comment on "systematic review of guidelines on cardiovascular risk assessment: which recommendations should clinicians follow for a cardiovascular health check?".高危心血管疾病筛查：指南面临的一项挑战：评《心血管风险评估指南的系统评价：心血管健康检查临床医生应遵循哪些建议？》
Arch Intern Med. 2010 Jan 11;170(1):40-2. doi: 10.1001/archinternmed.2009.457.
4
Headed in the right direction but at risk for miscalculation: a critical appraisal of the 2013 ACC/AHA risk assessment guidelines.方向正确，但存在计算错误的风险：对 2013 年 ACC/AHA 风险评估指南的批判性评价。
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2789-94. doi: 10.1016/j.jacc.2014.04.010. Epub 2014 May 7.
5
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).2014年欧洲心脏病学会/欧洲麻醉学会非心脏手术心血管评估和管理指南：非心脏手术心血管评估和管理联合工作组：欧洲心脏病学会（ESC）和欧洲麻醉学会（ESA）
Eur J Anaesthesiol. 2014 Oct;31(10):517-73. doi: 10.1097/EJA.0000000000000150.
6
Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.预防方面的进展：我们应该筛查风险因素还是疾病？心血管事件预防领域的当前争论。
J Cardiovasc Nurs. 2009 Jan-Feb;24(1):18-20. doi: 10.1097/01.JCN.0000343558.14237.70.
7
The global cardiovascular crisis: glove up.全球心血管危机：做好准备。
J Am Coll Cardiol. 2014 Dec 2;64(21):2300-1. doi: 10.1016/j.jacc.2014.09.027. Epub 2014 Nov 24.
8
Current European guidelines for management of cardiovascular disease: Is medical treatment in nearly half a population realistic?当前欧洲心血管疾病管理指南：近半数人口的医疗治疗现实吗？
Eur J Prev Cardiol. 2018 Jan;25(2):157-163. doi: 10.1177/2047487317738826. Epub 2017 Nov 2.
9
Global burden of cardiovascular disease: time to implement feasible strategies and to monitor results.心血管疾病的全球负担：是时候实施可行策略并监测结果了。
J Am Coll Cardiol. 2014 Aug 5;64(5):520-2. doi: 10.1016/j.jacc.2014.06.1151.
10
European guidelines on cardiovascular disease and prevention in clinical practice.欧洲临床实践中心血管疾病与预防指南。
Atherosclerosis. 2003 Nov;171(1):145-55. doi: 10.1016/j.atherosclerosis.2003.10.001.

引用本文的文献

1
Applicability and Risk Stratification of QRISK®, Framingham Risk Score, Systematic Coronary Risk Evaluation (SCORE), and American College of Cardiology/American Heart Association (ACC/AHA) Risk Assessment Tools Among Patients in Taif, Saudi Arabia.QRISK®、弗雷明汉风险评分、系统性冠状动脉风险评估（SCORE）以及美国心脏病学会/美国心脏协会（ACC/AHA）风险评估工具在沙特阿拉伯塔伊夫患者中的适用性及风险分层
Cureus. 2025 Jun 28;17(6):e86910. doi: 10.7759/cureus.86910. eCollection 2025 Jun.
2
Evolving Concepts of the SCORE System: Subtracting Cholesterol from Risk Estimation: A Way for a Healthy Longevity?SCORE系统的演变概念：从风险评估中减去胆固醇：实现健康长寿的一种方式？
Life (Basel). 2024 May 24;14(6):679. doi: 10.3390/life14060679.
3

本文引用的文献

1
ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study.在非糖尿病欧洲人中，美国心脏病学会/美国心脏协会（ACC/AHA）关于他汀类药物一级预防的指南优于欧洲心脏病学会/欧洲动脉粥样硬化学会（ESC/EAS）指南：哥本哈根普通人群研究。
Eur Heart J. 2017 Feb 21;38(8):586-594. doi: 10.1093/eurheartj/ehw426.
2
The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen General Population Study.在一项针对30824名欧洲人的当代人群（哥本哈根普通人群研究）中，高密度脂蛋白调整后的SCORE模型使基于SCORE的风险分类恶化。
Eur Heart J. 2015 Sep 21;36(36):2446-53. doi: 10.1093/eurheartj/ehv251. Epub 2015 Jun 16.
3
A cost-effectiveness evaluation of a high-sensitivity troponin I guided voluntary cardiovascular risk assessment program for asymptomatic women in Croatia.
克罗地亚针对无症状女性开展的一项基于高敏肌钙蛋白I的自愿性心血管风险评估项目的成本效益评估。
Int J Cardiol Cardiovasc Risk Prev. 2024 Feb 10;20:200244. doi: 10.1016/j.ijcrp.2024.200244. eCollection 2024 Mar.
4
Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment.血清和尿液可溶性α-klotho 作为肾脏和血管损伤的标志物。
Nutrients. 2023 Mar 18;15(6):1470. doi: 10.3390/nu15061470.
5
Subendocardial Viability Ratio Predictive Value for Cardiovascular Risk in Hypertensive Patients.心肌下存活比对高血压患者心血管风险的预测价值。
Medicina (Kaunas). 2022 Dec 22;59(1):24. doi: 10.3390/medicina59010024.
6
Targeting a Silent Disease: Vascular Calcification in Chronic Kidney Disease.靶向沉默之疾：慢性肾脏病中的血管钙化。
Int J Mol Sci. 2022 Dec 17;23(24):16114. doi: 10.3390/ijms232416114.
7
Cardiovascular Risk Prediction Models and Scores in the Era of Personalized Medicine.个性化医疗时代的心血管疾病风险预测模型与评分
J Pers Med. 2022 Jul 20;12(7):1180. doi: 10.3390/jpm12071180.
8
Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines.根据 2021 年欧洲预防指南与其他国际指南相比，他汀类药物用于心血管疾病一级预防的适宜性。
JAMA Cardiol. 2022 Aug 1;7(8):836-843. doi: 10.1001/jamacardio.2022.1876.
9
Large health disparities in cardiovascular death in men and women, by ethnicity and socioeconomic status in an urban based population cohort.在一个以城市为基础的人群队列中，按种族和社会经济地位划分，男性和女性在心血管疾病死亡方面存在巨大的健康差异。
EClinicalMedicine. 2021 Aug 29;40:101120. doi: 10.1016/j.eclinm.2021.101120. eCollection 2021 Oct.
10
Understanding providers' attitudes and key concerns toward incorporating CVD risk prediction into clinical practice: a qualitative study.了解提供者对将 CVD 风险预测纳入临床实践的态度和主要关注点：一项定性研究。
BMC Health Serv Res. 2021 Jun 7;21(1):561. doi: 10.1186/s12913-021-06540-y.
Real-life evaluation of European and American high-risk strategies for primary prevention of cardiovascular disease in patients with first myocardial infarction.欧美针对首次心肌梗死患者心血管疾病一级预防的高危策略的实际评估。
BMJ Open. 2014 Oct 17;4(10):e005991. doi: 10.1136/bmjopen-2014-005991.
4
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会/美国心脏协会成人降低动脉粥样硬化性心血管风险的血胆固醇治疗指南：美国心脏病学会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934. doi: 10.1016/j.jacc.2013.11.002. Epub 2013 Nov 12.
5
Increasing prevalence despite decreasing incidence of ischaemic heart disease and myocardial infarction. A national register based perspective in Denmark, 1980-2009.尽管缺血性心脏病和心肌梗死的发病率在下降，但其患病率却在上升。基于丹麦国家登记处1980 - 2009年的视角。
Eur J Prev Cardiol. 2015 Feb;22(2):189-95. doi: 10.1177/2047487313509495. Epub 2013 Oct 28.
6
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).《欧洲临床实践心血管疾病预防指南》（2012年版）。欧洲心脏病学会及其他学会心血管疾病预防临床实践联合工作组第五版（由九个学会的代表及特邀专家组成）。
Eur Heart J. 2012 Jul;33(13):1635-701. doi: 10.1093/eurheartj/ehs092. Epub 2012 May 3.
7
Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.评估心血管风险的现有评分的价值与局限性：临床医生综述
J Am Coll Cardiol. 2009 Sep 29;54(14):1209-27. doi: 10.1016/j.jacc.2009.07.020.
8
Predictive ability of the SCORE Belgium risk chart for cardiovascular mortality.比利时 SCORE 风险图表对心血管死亡率的预测能力。
Int J Cardiol. 2010 Sep 3;143(3):385-90. doi: 10.1016/j.ijcard.2009.03.101. Epub 2009 Apr 22.
9
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.欧洲临床实践中心血管疾病预防指南。欧洲及其他学会心血管疾病预防临床实践联合工作组第三次报告
Eur Heart J. 2003 Sep;24(17):1601-10. doi: 10.1016/s0195-668x(03)00347-6.
10
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.欧洲致命性心血管疾病十年风险评估：SCORE项目
Eur Heart J. 2003 Jun;24(11):987-1003. doi: 10.1016/s0195-668x(03)00114-3.